Actinium Pharmaceuticals (ATNM) Stock Chart & Stock Price History $1.40 +0.18 (+14.75%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsTrends Actinium Pharmaceuticals Stock Price Performance 5 Day Performance+11.11%1 Month Performance+20.69%3 Month Performance-23.08%6 Month Performance-81.08%Year-To-Date Performance+11.11%1 Year Performance-72.44% Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ATNM Stock Chart for Saturday, January, 18, 2025 ATNM Chart by TradingView Actinium Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/17/2025$1.22$1.40+14.75%$1.40$1.22453,900 shs$43.68 million01/16/2025$1.22$1.22$1.23$1.18139,968 shs$38.06 million01/15/2025$1.22$1.22$1.27$1.20122,774 shs$38.06 million01/14/2025$1.26$1.22-3.17%$1.27$1.17233,566 shs$38.06 million01/13/2025$1.28$1.26-1.56%$1.30$1.24113,770 shs$39.31 million01/10/2025$1.31$1.28-2.29%$1.31$1.25216,306 shs$39.93 million01/09/2025$1.31$1.31$1.42$1.31165,453 shs$40.87 million01/08/2025$1.39$1.31-5.76%$1.42$1.31165,453 shs$40.87 million01/07/2025$1.43$1.39-2.80%$1.47$1.36206,813 shs$43.36 million01/06/2025$1.44$1.43-0.69%$1.48$1.39283,683 shs$44.61 million Get the Latest News and Ratings for ATNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/03/2025$1.26$1.44+14.29%$1.45$1.27388,264 shs$44.92 million01/02/2025$1.26$1.26$1.34$1.25465,583 shs$39.31 million01/01/2025$1.26$1.26$1.28$1.17580,085 shs$39.31 million12/31/2024$1.17$1.26+7.69%$1.28$1.17580,085 shs$39.31 million12/30/2024$1.20$1.17-2.50%$1.22$1.16418,708 shs$36.50 million12/27/2024$1.29$1.20-6.98%$1.29$1.18475,707 shs$37.44 million12/26/2024$1.22$1.29+5.74%$1.29$1.17295,859 shs$40.24 million12/25/2024$1.22$1.22$1.24$1.15141,941 shs$38.06 million12/24/2024$1.24$1.22-1.61%$1.24$1.15141,941 shs$38.06 million12/23/2024$1.29$1.24-3.88%$1.29$1.19301,335 shs$38.68 million12/20/2024$1.12$1.29+15.18%$1.29$1.131.08 million shs$40.24 million12/19/2024$1.16$1.12-3.45%$1.20$1.10356,415 shs$34.94 million12/18/2024$1.22$1.16-4.92%$1.26$1.16383,402 shs$36.19 million12/17/2024$1.28$1.22-4.69%$1.29$1.22294,597 shs$38.06 million Related Companies Actuate Therapeutics Stock Price Chart Checkpoint Therapeutics Stock Price Chart Puma Biotechnology Stock Price Chart Cidara Therapeutics Stock Price Chart Innate Pharma Stock Price Chart Adaptimmune Therapeutics Stock Price Chart Biomea Fusion Stock Price Chart Fate Therapeutics Stock Price Chart Sutro Biopharma Stock Price Chart TScan Therapeutics Stock Price Chart Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ATNM) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredDonald Trump is about to free crypto from its chains …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinium Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actinium Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATNM Stock Alerts